New study suggests J&J recipients should get booster shot to protect against Delta variant

Johnson & Johnson COVID-19 vaccine.
(Image credit: AP Photo/David Zalubowski, File)

Recipients of the one-shot Johnson & Johnson COVID-19 vaccine may need to get a second dose to protect against the Delta and Lambda coronavirus variants because its less effective against them, a new study suggests, per The New York Times.

"The message that we wanted to give was not that people shouldn't get the J&J vaccine, but we hope that in the future, it will be boosted with either one dose of J&J or a booster with [the Pfizer and Moderna COVID-19 vaccines]," Nathaniel Landau, a virologist at New York University's Grossman School of Medicine who led the study, told the Times.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.